Technology ID
TT-0112
Description
Therapeutic potential of resveratrol, polydatin, and/or their analogues as eye drops for age-related macular degeneration (AMD) through angiogenic inhibition.
Content
Solid foundation and clinical applications of VEGF-targeted drugs from traditional Chinese medicines (TCMs), supported by 7 publications and 3 patents (1 filed, 2 in progress)
Phytochemicals targeting VEGF offering easy administration, low-cost manufacturing, potential for long-term use and simple topical application
New therapeutic and non-invasive strategy providing advantages over standard treatment options such as argon laser photocoagulation and photodynamic therapy
Inventors
Applicable Industries
Potential Application
Technology Focus
TRL
Images
